0a46e0e2_Text_View___ClinicalTrials_gov__Assigned_Interventions
[Arms] Experimental: 4 Participants in this group will receive a continuous regimen of teriparatide (20 mcg delivered subcutaneously) daily for 48 months. Biopsies will be performed at Week 7 or Month 7.5. At 24 months the participants will then have the option of taking alendronate and remaining in the study for another 24 months. [Assigned Interventions] 
Drug: Teriparatide Teriparatide will be given subcutaneously in 20-mcg doses either continuously or cyclically. Dietary Supplement: Calcium Calcium supplements will be administered in varied amounts for all participants, but each participant will take enough to bring her total daily calcium intake to 1,200 mg. Dietary Supplement: Vitamin D3 Vitamin D3 supplements will be administered in varied amounts for all participants, but each participant will take enough to bring her total daily intake to 1,200 mg.
Cyclic Versus Daily Teriparatide on Bone Mass - Full Text View - ClinicalTrials.gov